AKT1 and hepatocellular carcinoma: In vivo experiments show similar results, bufalin can inhibit tumor growth in mice with orthotopic transplantation tumor models of HCC through the Akt/GSK3β/β-catenin/E-cadherin pathway, promoting tumor necrosis (Zhang et al., 2014).